oligohydramnios
Conditions
Interventions
sildenafil citrate
Fluid therapy
Sponsors
menoufiya university hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Pregnant women will be included if they are of any age, any parity, carrying a singleton pregnancy, at a gestational age (GA) 30 weeks or more (based on the last menstrual period and confirmed by the results of ultrasound or determined through early pregnancy sonography), they have an AFI ¿ 5, no pregnancy complications such as preeclampsia, gestational hypertension, or diabetes, no prior history of kidney, lung, and heart disease (the use of bolus-fluid therapy is contraindicated in these patients), and intact fetal membranes.
Exclusion criteria
Exclusion criteria: Mothers treated with prostaglandin synthetase inhibitors, well established labor, evidence of fetal distress (non-reactive non stress test), or fetal complications (intrauterine growth retardation or obvious fetal anomalies) are considered exclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the values of AFI before and after therapy in each group and between both groups. | — |
Countries
Egypt
Outcome results
None listed